# Albaugh Marijuana Research Cited in Scientific American Article – University of Vermont > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/albaugh-marijuana-research-cited-in-scientific-american-article-university-of-vermont/ > **Published:** 2026-05-18T20:16:48-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T17:00:24-04:00 > **Clinical Summary:** Academic cannabis research clinical evidence advances peer-reviewed cannabinoid studies from University of Vermont. --- ✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. Research[Mental Health](https://cedclinic.com/cannabis-psychiatric-research-findings-depression-anxiety/)NeurologyTHCCBDSafetyAnxiety Dr. Caplan’s Take “The neuroimaging work coming out of Vermont and similar labs is finally giving us objective markers for what we’ve observed clinically for years: that cannabis affects [brain structure](https://cedclinic.com/long-term-heavy-cannabis-use-linked-brain-changes/) and function in measurable ways, particularly in adolescents and heavy users, and this evidence needs to inform how we counsel patients about risk stratification and dosing—especially when we’re considering cannabis as a therapeutic option rather than reflexively recommending it.” Clinical Perspective Recent research highlighting [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) and psychiatric outcomes underscores the importance of clinicians obtaining thorough [substance use](https://cedclinic.com/stroke-risk-assessment-substance-use/) histories during [mental health](https://cedclinic.com/cannabis-psychiatric-research-findings-depression-anxiety/) assessments. While cannabis is increasingly legalized and normalized across many jurisdictions, emerging neuroscientific evidence suggests potential associations between use patterns and psychiatric symptoms that warrant clinical attention. However, individual responses vary considerably based on genetics, age at initiation, frequency of use, product potency, and underlying psychiatric vulnerabilities, making sweeping clinical pronouncements difficult. Providers should recognize that patients may not spontaneously disclose [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) due to lingering stigma or evolving legal landscapes, requiring nonjudgmental inquiry. In practice, this translates to incorporating cannabis-specific questions into psychiatric and [substance use](https://cedclinic.com/stroke-risk-assessment-substance-use/) screening protocols and remaining current with the psychiatric literature to provide informed counseling about potential risks, particularly for patients with personal or family histories of psychotic disorders. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-related-research/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Albaugh%20Marijuana%20Research%20Cited%20in%20Scientific%20American%20Article%20-%20University%20of%20Vermont%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D55407)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D55407)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Albaugh%20Marijuana%20Research%20Cited%20in%20Scientific%20American%20Article%20-%20University%20of%20Vermont%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D55407)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) 📰 Source: [https://www.uvm.edu/larnermed/medcommunications/news/albaugh-marijuana-research-cited-scientific-american-article](https://www.uvm.edu/larnermed/medcommunications/news/albaugh-marijuana-research-cited-scientific-american-article) Further Reading Cannabis Policy Wire[Schedules of Controlled Substances: Placement of MDMB-4en-PINACA in Schedule I](https://cedclinic.com/mdmb-4en-pinaca-schedule-i-placement/) CED Clinic Blog[Fear of recurrence, secondary cancers, and health problems in long-term survivors of childhood cancer: Findings from a Canadian cohort.](https://cedclinic.com/fear-of-recurrence-secondary-cancers-and-health-problems-in-long-term-survi/) CED Clinic Blog[Associations of cannabis use, other substances, and lifestyle choices on anxiety in medical cannabis patients across 45 days.](https://cedclinic.com/associations-of-cannabis-use-other-substances-and-lifestyle-choices-on-anxi/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).